Detection of bladder cancer in urine sediments by a hypermethylation panel of selected tumor suppressor genes

Ferlay J. , Autier P. , Boniol M. , Heanue M. , Colombet M. , Boyle P. , Estimates of the cancer incidence and mortality in Europe in 2006, Ann Oncol 18 (2007), 581-592.

van Rhijn B.W. , Burger M. , Lotan Y. , Solsona E. , Stief C.G. , Sylvester R.J. , Witjes J.A. , Zlotta A.R. , Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy, Eur Urol 56 (2009), 430-442.

Moch H. , Humphrey P.A. , Ulbright T.M. , Reuter V.E. , WHO Classification of Tumours of the Urinary System and Male Genital Organs, in: IARC WHO Classification of Tumours, 4th ed., vol. 8, 2016.

van der Aa M.N. , Steyerberg E.W. , Sen E.F. , Zwarthoff E.C. , Kirkels W.J. , van der Kwast T.H. , Essink-Bot M.L. , Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison, BJU Int 101 (2008), 1106-1110.

van Rhijn B.W. , van der Poel H.G. , van der Kwast T.H. , Urine markers for bladder cancer surveillance: a systematic review, Eur Urol 47 (2005), 736-748.

Beukers W. , Kandimalla R. , Masius R.G. , Vermeij M. , Kranse R. , van Leenders G.J.L.H. , Zwarthof E.C. , Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer, Mod Pathol 28 (2015), 515-522.

Kandimalla R. , van Tilborg A.A. , Kompier L.C. , Stumpel D.J. , Stam R.W. , Bangma C.H. , Zwarthoff E.C. , Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers, Eur Urol 61 (2012), 1245-1256.

Têtu B. , Diagnosis of urothelial carcinoma from urine, Mod Pathol 22 (2009), 53-59.

Lokeshwar V.B. , Habuchi T. , Grossman H.B. , Murphy W.M. , Hautmann S.H. , Hemstreet G.P. , Bono A.V. , Getzenberg R.H. , Goebell P. , Schmitz-Dräger B.J. , Schalken J.A. , Fradet Y. , Marberger M. , Messing E. , Droller M.J. , Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers, Urology 66 (2005), 35-63.

Catto J.W. , Azzouzi A.R. , Rehman I. , Feeley K.M. , Cross S.S. , Amira N. , Fromont G. , Sibony M. , Cussenot O. , Meuth M. , Hamdy F.C. , Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma, J Clin Oncol 23 (2005), 2903-2910.

Hoque M.O. , Begum S. , Topaloglu O. , Chatterjee A. , Rosenbaum E. , Van Criekinge W. , Westra W.H. , Schoenberg M. , Zahurak M. , Goodman S.N. , Sidransky D. , Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection, J Natl Cancer Inst 98 (2006), 996-1004.

Yates D.R. , Rehman I. , Meuth M. , Cross S.S. , Hamdy F.C. , Catto J.W. , Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls, Oncogene 25 (2006), 1984-1988.

Chan M.W. , Chan L.W. , Tang N.L. , Tong J.H. , Lo K.W. , Lee T.L. , Cheung H.Y. , Wong W.S. , Chan P.S. , Lai F.M. , To K.F. , Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients, Clin Cancer Res 8 (2002), 464-470.

Dulaimi E. , Uzzo R.G. , Greenberg R.E. , Al-Saleem T. , Cairns P. , Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel, Clin Cancer Res 10 (2004), 1887-1893.

Gudjónsson S. , Isfoss B.L. , Hansson K. , Domanski A.M. , Warenholt J. , Soller W. , Lundberg L.M. , Liedberg F. , Grabe M. , Månsson W. , The Value of the UroVysion^® Assay for Surveillance of Non-Muscle-Invasive Bladder Cancer, Eur Urol 54 (2008), 402-408.

Daniely M. , Rona R. , Kaplan T. , Olsfanger S. , Elboim L. , Zilberstien Y. , Friberger A. , Kidron D. , Kaplan E. , Lew S. , Leibovitch I. , Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples, Urology 66 (2005), 1354-1359.

Chuang K.L. , Chuang H.C. , Ng K.F. , Chang Y.H. , Wu C.T. , Chuang C.K. , Liao S.K. , Pang S.T. , Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients, BJU Int 105 (2010), 1413-1416.

Bubendorf L. , Multiprobe Fluorescence in situ Hybridization (UroVysion) for the Detection of Urothelial Carcinoma - FISHing for the Right Catch, Acta Cytol 55 (2011), 113-119.

Rebouissou S. , Hérault A. , Letouzé E. , Neuzillet Y. , Laplanche A. , Ofualuka K. , Maillé P. , Leroy K. , Riou A. , Lepage M.L. , Vordos D. , de la Taille A. , Denoux Y. , Sibony M. , Guyon F. , Lebret T. , Benhamou S. , Allory Y. , Radvanyi F. , CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma, J Pathol 227 (2012), 315-324.

Gao T. , Wang S. , He B. , Pan Y. , Song G. , Gu L. , Chen L. , Nie Z. , Xu Y. , Li R. , The association of RAS association domain family Protein1A (RASSF1A) methylation states and bladder cancer risk: a systematic review and meta-analysis, PLoS One 7 (2012), e48300.

Eissa S. , Swellam M. , El-Khouly I.M. , Kassim S.K. , Shehata H. , Mansour A. , Esmat M. , Nossier A.I. , Hamdy M.A. , Awad N.M. , El-Ahmady O. , Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer, Cancer Epidemiol Biomarkers Prev 20 (2011), 1657-1664.